Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor adverse events, safety and tolerance Metoprolol
Succinate Extended-Release Tablets 200 mg under fasting conditions